⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2079695 | 1.00 | — | — | |
| SCHEMBL2079700 | 1.00 | — | — | |
| SCHEMBL2081086 | 0.86 | CHRM2 (0.34) | — | |
| SCHEMBL2081089 | 0.86 | CHRM2 (0.34) | — | |
| SCHEMBL2081081 | 0.86 | CHRM2 (0.34) | — | |
| SCHEMBL2081015 | 0.78 | RIPK1 (0.32) | — | |
| SCHEMBL376576 | 0.78 | MMP2 (0.32) | — | |
| SCHEMBL2080379 | 0.75 | ALDH1A1 (0.34) | — | |
| SCHEMBL2080381 | 0.75 | ALDH1A1 (0.34) | — | |
| SCHEMBL2080384 | 0.75 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7906532-B2 | Antiserotonine agents; gastrointestinal disorders; irritable bowel syndrome; central nervous system disorders; Alzheimer's disease; cognition activators; analgesics; cardiovascular disorders; antidiabetic agents; sleep disorders | PFIZER INC. (US) | 2011-03-15 | — | — | US | disclosed |
| EP-1910340-B1 | INDAZOLECARBOXAMIDE DERIVATIVES AS 5HT4 RECEPTOR AGONISTS | PFIZER (US) | 2009-11-18 | — | — | EP | disclosed |
| US-20080269211-A1 | Indazole Derivatives | PFIZER INC | 2008-10-30 | — | — | US | disclosed |